Solstice Pharmaceuticals B.V. is a Dutch startup focused on innovating ultrasound contrast agents for improved diagnostic and therapeutic ultrasound applications. Their dedication lies in creating the next generation of products in the field. The company's slogan reflects this commitment: "Innovating Ultrasound Contrast Agents for improved diagnostic and therapeutic ultrasound applications." Founded in 2020, Solstice Pharmaceuticals operates within the Biotechnology, Health and Wellness, and Pharmaceutical industries. The company's headquarters is based in The Netherlands. Solstice Pharmaceuticals has yet to secure its last investment or disclose the identity of its last investment investors. This startup presents a compelling opportunity in the healthcare and biotechnology sectors, with a focus on leveraging ultrasound technology to improve medical diagnostics and therapies.
There is no investment information
No recent news or press coverage available for Solstice Pharmaceuticals B.V..